Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Change in Accured Expenses (2016 - 2020)

Historic Change in Accured Expenses for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to -$143000.0.

  • Glucotrack's Change in Accured Expenses rose 1551.86% to -$143000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$236000.0, marking a year-over-year increase of 1890.03%. This contributed to the annual value of $332000.0 for FY2023, which is 14057.97% up from last year.
  • Per Glucotrack's latest filing, its Change in Accured Expenses stood at -$143000.0 for Q4 2020, which was up 1551.86% from $55000.0 recorded in Q3 2020.
  • In the past 5 years, Glucotrack's Change in Accured Expenses registered a high of $937276.0 during Q1 2017, and its lowest value of -$766248.0 during Q2 2017.
  • For the 5-year period, Glucotrack's Change in Accured Expenses averaged around $34653.1, with its median value being $29536.0 (2018).
  • Within the past 5 years, the most significant YoY rise in Glucotrack's Change in Accured Expenses was 32819.34% (2016), while the steepest drop was 265373.11% (2016).
  • Glucotrack's Change in Accured Expenses (Quarter) stood at $133830.0 in 2016, then skyrocketed by 99.94% to $267582.0 in 2017, then plummeted by 74.5% to $68237.0 in 2018, then tumbled by 348.06% to -$169268.0 in 2019, then grew by 15.52% to -$143000.0 in 2020.
  • Its Change in Accured Expenses stands at -$143000.0 for Q4 2020, versus $55000.0 for Q3 2020 and -$99000.0 for Q2 2020.